Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Natalizumab and multiple sclerosis.
Transcription factor-mediated reprogramming of fibroblasts to expandable, myelinogenic oligodendrocyte progenitor cells.
Ustekinumab in chronic immune-mediated diseases: a review of long term safety and patient improvement.
Predicting Breakdown of the Blood-Brain Barrier in Multiple Sclerosis without Contrast Agents.
Transverse myelitis with Brown-Sèquard syndrome after H1N1 immunization.
Falls in people with multiple sclerosis compared with falls in healthy controls.
Multiple sclerosis: Blood-based biomarkers provide insight into progressive MS.
Retrograde degeneration of visual pathway: hemimacular thinning of retinal ganglion cell layer in progressive and active multiple sclerosis.
Matrine ameliorates experimental autoimmune encephalomyelitis by modulating chemokines and their receptors.
Reply to comment: Month of birth and risk of multiple sclerosis: confounding and adjustments.
Targeting of ECM molecules and their metabolizing enzymes and receptors for the treatment of CNS diseases.
Intermediate uveitis and multiple sclerosis: to scan or not to scan.
Recurrent Optic Neuritis in Children.
A Case Report of Post Rabipur (Purified Chick Embryo Rabies Vaccine) Acute Disseminated Encephalomyelitis.
The role of parvovirus B19 in the pathogenesis of autoimmunity and autoimmune disease.
Being Kind to Your Future Self: Probability Discounting of Health Decision-Making.
The neuroimaging of Leigh syndrome: case series and review of the literature.
Increased CSF sulfatide levels and serum glycosphingolipid antibody levels in healthy siblings of multiple sclerosis patients.
Cerebrospinal fluid oligoclonal IgM bands predict early conversion to clinically definite multiple sclerosis in patients with Clinically Isolated Syndrome.
Genetic overlap between multiple sclerosis and several cardiovascular disease risk factors.
Drugs in clinical development for multiple sclerosis: focusing on anti-CD20 antibodies.
Adding to the burden: gastrointestinal symptoms and syndromes in multiple sclerosis.
Plasmacytoid dendritic cells and autoimmune inflammation.
Rapid parametric mapping of the longitudinal relaxation time t1 using two-dimensional variable flip angle magnetic resonance imaging at 1.5 tesla, 3 tesla, and 7 tesla.
Recognising and diagnosing inflammatory brain disease.
Pages
« first
‹ previous
…
462
463
464
465
466
467
468
469
470
…
next ›
last »